Adipotide: A Metabolic Research Overview
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. Adipotide, also written as FTPP (fat-targeted proapoptotic peptide), is a peptidomimetic compound that has drawn attention in published research for its proposed mechanism of targeting the blood vessels that supply white adipose tissue. This overview summarizes how researchers describe Adipotide in the early and preclinical literature, with an emphasis on its design, reported mechanism, and the experimental questions that remain open. It is written for investigators and students surveying the metabolic-research landscape, not as guidance for any form of use.
What Adipotide (FTPP) Is in the Research Literature
Adipotide is described in published research as a chimeric peptide built from two functional segments joined together. One segment is a homing motif (the sequence CKGGRAKDC) that researchers identified through in vivo phage-display screening as a peptide that associates with the vasculature of white fat. The second segment is a proapoptotic sequence intended to trigger programmed cell death once the molecule localizes. In this two-part design, the homing portion is studied as a way to concentrate activity at a specific tissue's blood supply, while the effector portion is studied for its capacity to induce apoptosis. This modular "address plus payload" architecture is a recurring theme across the targeted-peptide field, and Adipotide is frequently used as a reference example when researchers discuss vasculature-directed constructs.
Because Adipotide is a research compound rather than an approved product, laboratories that study peptides typically handle reconstitution and handling under standardized protocols. Investigators new to lyophilized peptides often review general procedures such as those outlined in this guide to reconstituting peptides before designing any benchtop experiment.
The Proposed Mechanism: Targeting Adipose Vasculature
The central hypothesis in the Adipotide literature is that white adipose tissue, like a tumor, depends on its own blood-vessel network, and that selectively disrupting that network may cause the tissue to regress. In published research, the CKGGRAKDC homing motif was reported to associate with prohibitin, a multifunctional membrane protein that the same work proposed as a vascular marker of adipose tissue. By coupling the homing motif to a proapoptotic sequence, researchers studied whether apoptosis could be induced in the endothelial cells of fat vasculature specifically, rather than systemically.
Subsequent vascular-mapping research has continued to examine prohibitin in the context of white adipose tissue blood vessels, reinforcing why the protein became a focal point for targeted-construct design. Within the research framing, prohibitin functions as the molecular "address" that the homing motif recognizes. It is important to note that these are mechanistic descriptions drawn from experimental models; the literature does not establish any clinical outcome, and researchers continue to study the specificity, off-target distribution, and pharmacology of such constructs.
Preclinical Status and Open Research Questions
Adipotide is best characterized as an early-stage, preclinical research compound. The published work that introduced the targeting strategy was conducted in animal models, and much of the surrounding literature concerns the underlying biology of adipose vasculature rather than any standardized therapeutic protocol. Researchers studying the compound have raised a number of open questions, including how prohibitin expression differs across tissues, how selective the homing motif is in practice, and how proapoptotic payloads behave pharmacokinetically. These are exactly the kinds of variables that controlled laboratory studies are designed to probe.
For investigators comparing Adipotide to other metabolic-research constructs, structured catalogs and lookup tools can help map the landscape. The research finder is one way to cross-reference compounds by research category, and related materials grouped under the metabolic and adipose research category are organized for laboratory reference. As always, any experimental design should be reviewed against current literature and institutional protocols.
Some discussions of Adipotide circulate as unverified anecdotal reports, not controlled findings. BioRegen does not make or endorse any claims based on them. The peer-reviewed record, not informal accounts, is the appropriate basis for any research interpretation.
Frequently Asked Research Questions
What does the abbreviation FTPP mean?
In the research literature, FTPP is used as shorthand for a fat-targeted proapoptotic peptide. It refers to the two-part design concept of a homing motif joined to a proapoptotic effector sequence, which is the architecture researchers associate with Adipotide.
Why is prohibitin discussed alongside Adipotide?
Published research reported that the CKGGRAKDC homing motif associates with prohibitin and proposed prohibitin as a vascular marker of white adipose tissue. That association is why the protein is central to how researchers describe the compound's proposed targeting mechanism.
What stage of research is Adipotide in?
It is described in the literature as an early, preclinical research compound studied in experimental models. No clinical outcome is established, and it is not approved for human or veterinary use.
Selected Research References
- Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 2004. https://doi.org/10.1038/nm1048
- Staquicini FI, Cardo-Vila M, Kolonin MG, et al. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A. 2011. https://doi.org/10.1073/pnas.1114503108
Reference metadata sourced via PubMed.
Continue Your Research
To go deeper into compound handling, comparisons, and laboratory documentation, explore the BioRegen research guide and use code RESEARCH10 for 10% off your first order. You can also browse the metabolic and adipose research category to see related materials organized for laboratory reference.
All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. Statements describe published research and do not constitute any claim that any compound treats, cures, or prevents any disease.